These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39107179)

  • 1. Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery.
    Ma J; Del Balzo L; Walch H; Khaleel S; Knezevic A; Flynn J; Zhang Z; Eichholz J; Doshi SD; Voss MH; Freeman B; Ari Hakimi A; Lee CH; Bale TA; Kelly D; Mueller BA; Mann J; Yu Y; Zinovoy M; Chen L; Cuaron J; Khan A; Yamada Y; Shin JY; Beal K; Moss NS; Carlo MI; Motzer RJ; Imber BS; Kotecha RR; Pike LRG
    Eur Urol Oncol; 2024 Aug; ():. PubMed ID: 39107179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastases.
    Gui C; Walch HS; Mueller KD; Boe LA; Ilica AT; Strong J; Eichholz JE; Yu KKH; Wilcox JA; Manca P; Yu Y; Yamada Y; Imber BS; Maron SB; Foote MB; Yaeger R; Schultz N; Pike LRG
    J Neurosurg; 2024 Aug; ():1-11. PubMed ID: 39213675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases.
    Juloori A; Miller JA; Parsai S; Kotecha R; Ahluwalia MS; Mohammadi AM; Murphy ES; Suh JH; Barnett GH; Yu JS; Vogelbaum MA; Rini B; Garcia J; Stevens GH; Angelov L; Chao ST
    J Neurosurg; 2020 Jan; 132(1):188-196. PubMed ID: 30660120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Radiosurgery for Differentiated Thyroid Cancer Brain Metastases: An International, Multicenter Study.
    Bunevicius A; Fribance S; Pikis S; Lee JYK; Buch LY; Moran M; Yang AI; Bernstein K; Mathieu D; Perron R; Liscak R; Simonova G; Patel S; Trifiletti DM; Martínez Álvarez R; Martínez Moreno N; Lee CC; Yang HC; Strickland BA; Zada G; Chang EL; Kondziolka D; Sheehan J
    Thyroid; 2021 Aug; 31(8):1244-1252. PubMed ID: 33978475
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with brain metastases from renal cell carcinoma: inverse probability of treatment weighting using propensity scores.
    Yomo S; Oda K; Oguchi K
    J Neurosurg; 2023 Jun; 138(6):1591-1599. PubMed ID: 36308485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
    Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H
    Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
    J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of conformity index and gradient index in patients undergoing stereotactic radiosurgery for a single metastatic tumor.
    Aiyama H; Yamamoto M; Kawabe T; Watanabe S; Koiso T; Sato Y; Higuchi Y; Ishikawa E; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2018 Dec; 129(Suppl1):103-110. PubMed ID: 30544326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases.
    El Shafie RA; Celik A; Weber D; Schmitt D; Lang K; König L; Bernhardt D; Höne S; Forster T; von Nettelbladt B; Adeberg S; Debus J; Rieken S
    J Neurooncol; 2020 May; 147(3):607-618. PubMed ID: 32239433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Radiosurgery for Women Older than 65 with Breast Cancer Brain Metastases.
    Upadhyay R; Klamer BG; Perlow HK; White JR; Bazan JG; Jhawar SR; Blakaj DM; Grecula JC; Arnett A; Mestres-Villanueva MA; Healy EH; Thomas EM; Chakravarti A; Raval RR; Lustberg M; Williams NO; Palmer JD; Beyer SJ
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic Radiosurgery for Multiple Brain Metastases From Renal-Cell Carcinoma.
    Wardak Z; Christie A; Bowman A; Stojadinovic S; Nedzi L; Barnett S; Patel T; Mickey B; Whitworth T; Hannan R; Brugarolas J; Timmerman R
    Clin Genitourin Cancer; 2019 Apr; 17(2):e273-e280. PubMed ID: 30595522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
    Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
    J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
    Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
    Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of Stereotactic Radiosurgery for Renal Cell Carcinoma Brain Metastases.
    Haque W; Verma V; Butler EB; Teh BS
    Clin Genitourin Cancer; 2018 Aug; 16(4):e935-e943. PubMed ID: 29680768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF V600E mutation and BRAF kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases.
    Xu Z; Lee CC; Ramesh A; Mueller AC; Schlesinger D; Cohen-Inbar O; Shih HH; Sheehan JP
    J Neurosurg; 2017 Mar; 126(3):726-734. PubMed ID: 27203149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and outcomes in patients with ≥ 25 cumulative brain metastases treated with stereotactic radiosurgery.
    Benjamin CG; Gurewitz J; Kavi A; Bernstein K; Silverman J; Mureb M; Donahue B; Kondziolka D
    J Neurosurg; 2022 Aug; 137(2):571-581. PubMed ID: 34952524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with lung cancer and brain metastases: a propensity score-matched analysis.
    Yomo S; Oda K; Oguchi K
    J Neurosurg; 2023 Dec; 139(6):1628-1637. PubMed ID: 37243558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes of Upfront Stereotactic Radiosurgery Alone for Patients With 5 to 15 Brain Metastases.
    Hughes RT; McTyre ER; LeCompte M; Cramer CK; Munley MT; Laxton AW; Tatter SB; Ruiz J; Pasche B; Watabe K; Chan MD
    Neurosurgery; 2019 Aug; 85(2):257-263. PubMed ID: 29982831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.